Peer-Reviewed Articles from Managed Care


Treating Psoriasis Patients With Biologic Agents

Improved outcomes with new biologic agents are prompting physicians to integrate them into therapy for psoriasis patients.

David M. Pariser, MD


Case Study of a Failed Merger of Hospital Systems

What went wrong between Penn State and Geisinger, and what lessons should be learned?

Jaan Sidorov, MD


Balancing the Health Care Scorecard

A relatively new concept in strategic management provides a way to balance quality and customer satisfaction with costs and long-range goals.

Judith A. Shutt


Managing Perinatal Outcomes: The Clinical Benefit and Cost-Effectiveness of Pharmacologic Treatment of Recurrent Preterm Labor

Continuous subcutaneous terbutaline infusion shows improved clinical outcomes and decreased nursery costs compared with oral tocolytics in women with recurrent preterm labor.

Fung Lam, MD; Niki B. Istwan, RN, BS; Debbie Jacques, MPH; Suzanne K. Coleman, RNC, MS; Gary J. Stanziano, MD


A Health Care Management Company's Experience With Palivizumab – 1 Year Later

The appropriate application of criteria for the use of palivizumab can save health plans a significant amount of money.

William Silverman, MD, FAAP


Management of Moderate to Severe Plaque Psoriasis With Biologic Therapy

The impact of this debilitating disease has been largely underestimated, yet new biologic agents offer significant clinical benefit to those afflicted.

David M. Pariser, MD


Economic Analysis of Oral and Topical Therapies For Onychomycosis of the Toenails and Fingernails

Julian Casciano; Karine Amaya, PhD; John Doyle, MPH; Steve Arikian, MD; Neil Shear, MD


The Quandary of Compounding for MCOs: Administrative Costs, Risks, and Waste

Assuring the safety and efficacy of pharmaceuticals is important to any managed care organization. Compounding in the pharmacy needs scrutiny.

Thomas Kaye, RPh, MBA


Measuring Efficiency of Physician Practices Using Data Envelopment Analysis

Steven Andes, PhD, CPA; Lawrence M. Metzger, PhD, CPA; John Kralewski, PhD; David Gans, MSHA


Is 34 Weeks an Acceptable Goal For a Complicated Singleton Pregnancy?

J. Stephen Jones, MD; Niki B. Istwan, RN; Debbie Jacques, MPH; Suzanne K. Coleman, MSc; Gary Stanziano, MD

more